Equity Sell-Off - Timing the Buy - An opportunity like early in 2018? Thomas Schoenmaker Alpine Capital
M&A Spotlight: Takeda Pharmaceutical and Shire Pharmaceutical Pengana Capital Group Pengana Capital Group
